课题基金 / 基金详情

CLONING & EXPRESSION OF GROUP IV CYTOSOLIC CA2+ DEPENDENT PHOSPHOLIPASE

CLONING & EXPRESSION OF GROUP IV CYTOSOLIC CA2+ DEPENDENT PHOSPHOLIPASE
克隆
批准号:
6665863
负责人:
ZHONGMIN ALEX MA
金额:
$15.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2003-07-31

项目摘要

项目成果

ZHONGMIN ALEX MA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Stimulation of pancreatic islets with glucose induces phospholipid hydrolysis and accumulation of nonesterified arachidonic acid, which may play signaling or effector roles insulin secretion. Of enzymes that catalyze phospholipid hydrolysis, islet ?-cells express low molecular weight secretory phospholipases A2 (PLA2) and a Group VI, Ca2+-independent PLA2 (iPLA2). Previous studies indicate that islets also express a protein recognized by antibodies against a Group IV, cytosolic, Ca2+-dependent PLA2 (cPLA2). To further examine the possible expression of cPLA2 by islets, we screened a rat islet cDNA library with a probe that recognizes cPLA2 sequence and isolated a full-length cPLA2 cDNA. The rat islet cPLA2 deduced amino acid sequence is 96% identical to those of human and mouse cPLA2. Transfection of COS-7 cells with cPLA2 cDNA in an expression vector induced expression of Ca2+-dependent PLA2 activity and of a protein recognized by anti-cPLA2 antibody. Comparison of recombina nt islet cPLA2 and iPLA2 activities expressed in transfected COS-7 cells indicated that iPLA2 but not cPLA2 is stimulated by ATP. Both activities are similarly sensitive to inhibition by arachidonyltrifluoromethyl ketone, but iPLA2 is more effectively inhibited by a haloenol lactone suicide substrate than cPLA2. RT-PCR experiments with RNA from purified islet ?-cells and from an ?-cell-enriched population prepared by fluorescence-activated cell-sorting indicated that cPLA2 mRNA is more abundant in the ?-cell population. Immunoblotting analyses indicate that islets express cPLA2-immunoreactive protein and that interleukin-1 does not affect its expression. The cPLA2 is thus one of at least three classes of PLA2 enzymes with distinct properties expressed in ?-cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of DT-110 as an oral therapeutic for type 2 diabetes
  • 批准号:
    9046798
  • 项目类别:
  • 资助金额:
    $76.59万
  • 财政年份:
    2015
  • 负责人:
    ZHONGMIN ALEX MA
  • 依托单位:
Development of DT-109 as an oral therapeutic for type 2 diabetes
  • 批准号:
    8830889
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2015
  • 负责人:
    ZHONGMIN ALEX MA
  • 依托单位:
Development of DT-110 as an oral therapeutic for type 2 diabetes
  • 批准号:
    9146926
  • 项目类别:
  • 资助金额:
    $72.49万
  • 财政年份:
    2015
  • 负责人:
    ZHONGMIN ALEX MA
  • 依托单位:
PROTECTION OF PANCREATIC BETA-CELLS BY GROUP VIA PHOSPHOLIPASE A(2)
  • 批准号:
    8361459
  • 项目类别:
  • 资助金额:
    $0.83万
  • 财政年份:
    2011
  • 负责人:
    ZHONGMIN ALEX MA
  • 依托单位:
海外基金